BMC Medical Co. Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005WQ4
CNY
66.93
1.45 (2.21%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
BMC Medical Co. Ltd.

Why is BMC Medical Co. Ltd. ?

1
Positive results in Sep 25
  • NET SALES(HY) At CNY 542.93 MM has Grown at 32.42%
  • ROCE(HY) Highest at 7.28%
  • INTEREST COVERAGE RATIO(Q) Highest at 4,477.45
2
With ROE of 6.38%, it has a fair valuation with a 3.43 Price to Book Value
  • Over the past year, while the stock has generated a return of -9.69%, its profits have risen by 26.4% ; the PEG ratio of the company is 2
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to BMC Medical Co. Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is BMC Medical Co. Ltd. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
BMC Medical Co. Ltd.
-9.69%
0.25
46.77%
China Shanghai Composite
17.07%
1.07
14.99%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
3.29%
EBIT Growth (5y)
3.44%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.86
Sales to Capital Employed (avg)
0.35
Tax Ratio
9.84%
Dividend Payout Ratio
22.89%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
116.75%
ROE (avg)
9.36%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
54
Industry P/E
Price to Book Value
3.43
EV to EBIT
54.74
EV to EBITDA
45.60
EV to Capital Employed
17.43
EV to Sales
7.60
PEG Ratio
2.04
Dividend Yield
NA
ROCE (Latest)
31.85%
ROE (Latest)
6.38%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company
NET SALES(HY)

At CNY 542.93 MM has Grown at 32.42%

ROCE(HY)

Highest at 7.28%

INTEREST COVERAGE RATIO(Q)

Highest at 4,477.45

RAW MATERIAL COST(Y)

Fallen by -8.3% (YoY

NET PROFIT(Q)

At CNY 47.92 MM has Grown at 53.2%

-9What is not working for the Company
INTEREST(HY)

At CNY 2.81 MM has Grown at 38.62%

DEBT-EQUITY RATIO (HY)

Highest at -82.99 %

Here's what is working for BMC Medical Co. Ltd.

Interest Coverage Ratio
Highest at 4,477.45
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales
At CNY 542.93 MM has Grown at 32.42%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Net Profit
At CNY 47.92 MM has Grown at 53.2%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

Raw Material Cost
Fallen by -8.3% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for BMC Medical Co. Ltd.

Interest
At CNY 2.81 MM has Grown at 38.62%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debt-Equity Ratio
Highest at -82.99 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio